A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens

This publication has 16 references indexed in Scilit:

• An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system
  Vaccine, 1995
• Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supramolecular biovectors
  Vaccine, 1994
• Supramolecular biovectors (SMBV): a new family of nanoparticulate drug delivery systems. Synthesis and structural characterization
  International Journal of Pharmaceutics, 1994
• Modulation of antiviral immune responses by exogenous cytokines: effects of tumour necrosis factor- , interleukin-1 , interleukin-2 and interferon- on the immunogenicity of an inactivated rabies vaccine
  Journal of General Virology, 1994
• β-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus
  Vaccine, 1993
• A new immunostimulatory complex (PICKCa) in experimental rabies: antiviral and adjuvant effects
  Archiv für die gesamte Virusforschung, 1993
• Interleukin 2 Increases Protection against Experimental Rabies
  Immunobiology, 1988
• The ISCOM: an immunostimulating complex
  Immunology Today, 1987
• Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies
  Vaccine, 1985
• Étude de l'adsorption et de la pénétration du virus rabique: Interactions avec les cellules BHK21 et des membranes artificielles
  Annales de l'Institut Pasteur / Virologie, 1982